4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -159,506 | -102,630 | -47,972 | -160,868 | -111,197 |
| Depreciation Amortization | -109 | -216 | -216 | -2,529 | -1,775 |
| Accounts payable and accrued liabilities | 2,477 | 4,314 | -235 | 871 | -591 |
| Other Working Capital | 3,417 | -1,582 | -7,171 | 537 | 4,255 |
| Other Operating Activity | 16,088 | 8,979 | 7,836 | 27,404 | 20,586 |
| Operating Cash Flow | $-137,633 | $-91,135 | $-47,758 | $-134,585 | $-88,722 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -606 | -697 | -631 | -3,786 | -2,837 |
| Purchase Of Investment | -264,721 | -249,480 | -134,077 | -467,652 | -409,874 |
| Sale Of Investment | 301,201 | 268,273 | 166,656 | 169,001 | 103,215 |
| Investing Cash Flow | $35,874 | $18,096 | $31,948 | $-302,437 | $-309,496 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 978 | 862 | N/A | 337,250 | 336,649 |
| Financing Cash Flow | $978 | $862 | $N/A | $337,250 | $336,649 |
| Beginning Cash Position | 149,336 | 149,336 | 149,336 | 249,108 | 249,108 |
| End Cash Position | 48,555 | 77,159 | 133,526 | 149,336 | 187,539 |
| Net Cash Flow | $-100,781 | $-72,177 | $-15,810 | $-99,772 | $-61,569 |
| Free Cash Flow | |||||
| Operating Cash Flow | -137,633 | -91,135 | -47,758 | -134,585 | -88,722 |
| Capital Expenditure | -606 | -697 | -631 | -3,786 | -2,837 |
| Free Cash Flow | -138,239 | -91,832 | -48,389 | -138,371 | -91,559 |